Fibroblast growth factor receptor 3D receptor

4uwy – hFGFR1 TKD - human

1fgk, 3kxx, 3ky2, 4rwi, 5flf – hFGFR1 TKD (mutant) - human

4wun, 5am6, 5ew8, 5o49, 5o4a, 6mzw, 6c1o, 6mzq, 6mzw – hFGFR1 TKD + inhibitor

1agw, 1fgi, 2fgi, 3c4f, 3js2, 3rhx, 4f63, 4f64, 4f65, 3tt0, 4nk9, 4nka, 4nks, 5b7v, 5am7, 4rwj, 4rwk, 4rwl, 4uwb, 4uwc, 4zsa, 5uq0, 5vnd, 5ur1, 6c18, 6c19, 6c1b, 6c1c, 5z0s, 6agx, 6itj, 6nvl, 6p68, 6p69, 7ozb, 7ozd, 7ozf, 7ozy, 7wcw – hFGFR1 TKD (mutant) + inhibitor

5zv2, 7wcl – hFGFR1 TKD (mutant) + anti-cancer drug

3krj – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor

1xr0 – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR

3gqi – hFGFR1 TKD (mutant) with PTR + ACP

3gql – hFGFR1 TKD (mutant) + substrate

2cr3 – hFGFR1 LBD D1 - NMR

2ckn – FGFR1 LBD D1 – mouse - NMR

5w59 – hFGFR1 LBD D1 + FGF9

3ojv – hFGFR1 LBD D2,D3 (mutant) + hFGF1 - human

1cvs – hFGFR1 LBD D2,D3 (mutant) + hFGF2 (mutant)

1evt – hFGFR1 LBD D2,D3 + hFGF1

1fq9 – hFGFR1 (mutant) LBD D2,D3 + hFGF2 (mutant) + HS

5w21 – hFGFR1 LBD D2,D3 + hFGF23 + klotho

1gjo, 1oec, 2psq – hFGFR2 TKD

2pvy, 2pwl, 2py3, 2pz5, 2pzp, 2pzr, 2q0b, 4j95, 4j96, 4j97, 4j98, 4j99, 5ugx, 5uhn, 5ui0 – hFGFR2 TKD (mutant) + ACP

5ugl – hFGFR2 TKD (mutant) + ANP

3b2t – hFGFR2 TKD (mutant) + adenosine derivative

2pvf – hFGFR2 TKD with PTR + ACP + substrate peptide

3cly, 6v6q – hFGFR2 TKD (mutant) with PTR + ACP

5eg3 – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ

3ri1, 6lvk, 6lvl, 8e1x – hFGFR2 TKD + inhibitor

7kia, 7kie – hFGFR2 TKD (mutant) + inhibitor

3dar, 3caf, 3euu – hFGFR2 LBD D2 150-249

1wvz – hFGFR2 LBD D2 - NMR

4wv1 – hFGFR2 LBD D2 + antibody

6l4o – hFGFR2 LBD D2 (mutant) + API5

4hwu – hFGFR2 LBD D1 45-127

1e0o – hFGFR2 (mutant) LBD D2,D3 + hFGF1 (mutant) + HS

3oj2, 3ojm – hFGFR2 (mutant) LBD D2,D3 + hFGF1

1djs – hFGFR2 LBD D2,D3 (mutant) + hFGF1

1ev2, 1ii4, 1iil – hFGFR2 LBD D2,D3 + hFGF2 (mutant)

4j23 – hFGFR2 LBD D2,D3 (mutant) + hFGF2 (mutant) + inhibitor

3cu1 – hFGFR2 LBD D2 + hFGF1

2fdb – hFGFR2 LBD D2,D3 + hFGF8b

1nun – hFGFR2 LBD D2,D3 + hFGF10

3grw – hFGFR3 LBD D2,D3 + antibody

2lzl – hFGFR3 residues 357-399 – NMR

4k33 – hFGFR3 TKD (mutant)

6lvm, 7dhl – hFGFR3 TKD + inhibitor

6pnx – hFGFR3 TKD (mutant) + ACP

1ry7 – hFGFR3 LBD + hFGF1

4tye, 4tyg, 4tyi, 4tyj – hFGFR4 TKD

4qqj, 4qqt – hFGFR4 TKD (mutant)

5jkg, 5nwz, 5nud, [6nvg]], 6nvh, 6nvi, 6nvj, 6nvk, 6v9c, 7dtz, 7f3m, 7v29, 7vjl, 7wct, 7ybo, 7yc1, 7yc3 – hFGFR4 TKD + inhibitor

6yi8 – hFGFR4 TKD + drug

6jpj, 5xff, 5xfj, 6iuo, 6iup, 6jpe, 6jpj, 7wcx, 7ybp, 7ybx – hFGFR4 TKD (mutant) + inhibitor

4qrc, 4r6v, 4qqc, 4qq5, 4uxq, 4xcu – hFGFR4 TKD (mutant) + irreversible inhibitor

6j6y – hFGFR4 LBD D2 + antibody

7n1j, 7tyd – hFGFR4 LBD D3 + binder